All Stories

  1. Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014–2016

    Article • Contraception, March 2024, Elsevier

    Dr Marie Elisabeth Linder

  2. Estrogen-modulating treatment among mid-life women and COVID-19 morbidity and mortality: a multiregister nationwide matched cohort study in Sweden

    Article • BMC Medicine, February 2024, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  3. A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes

    Article • Journal of Health Population and Nutrition, November 2023, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  4. The association between exposure to clozapine, olanzapine, and quetiapine and the outcomes perimyocarditis and heart failure: A population-based cohort study

    Article • Psychiatry Research, August 2023, Elsevier

    Dr Marie Elisabeth Linder

  5. COVID-19 and comedications in atrial fibrillation—a case–control study in Stockholm

    Article • European Journal of Epidemiology, January 2023, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  6. Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics

    Article • British Journal of Clinical Pharmacology, October 2022, Wiley

    Dr Marie Elisabeth Linder

  7. 1591P Swedish national population-based study of direct oral anticoagulants and low molecular weight heparin treatment for thromboembolism in cancer patients: The OSCAR SWE study

    Article • Annals of Oncology, September 2022, Elsevier

    Dr Marie Elisabeth Linder

  8. Covid-19 and comedications in atrial fibrillation – a case-control study in Stockholm

    Article • August 2022, Research Square

    Dr Marie Elisabeth Linder

  9. Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources

    Article • Scientific Reports, April 2022, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  10. Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy

    Article • Obstetrics and Gynecology, April 2022, Wolters Kluwer Health

    Dr Marie Elisabeth Linder

  11. Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel—An observational cohort study in Sweden

    Article • Pharmacoepidemiology and Drug Safety, December 2021, Wiley

    Dr Marie Elisabeth Linder

  12. The use of uncertain exposure—A method to define switching and add‐on in pharmacoepidemiology

    Article • Pharmacoepidemiology and Drug Safety, October 2021, Wiley

    Dr Marie Elisabeth Linder

  13. Lessons Learned Using Real‐World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia

    Article • Clinical Pharmacology & Therapeutics, September 2021, Wiley

    Dr Marie Elisabeth Linder

  14. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease‐specific treatments: a French nationwide cohort study

    Article • British Journal of Haematology, August 2021, Wiley

    Dr Marie Elisabeth Linder

  15. Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe

    Article • Pharmacoepidemiology and Drug Safety, July 2021, Wiley

    Dr Marie Elisabeth Linder

  16. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, July 2021, Oxford University Press (OUP)

    Dr Marie Elisabeth Linder

  17. Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

    Article • Drug Safety, July 2021, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  18. Using epidemiological methods to quantify the risk of serious infections in children with atopic dermatitis

    Article • British Journal of Dermatology, June 2021, Oxford University Press (OUP)

    Dr Marie Elisabeth Linder

  19. Societal impact for patients with psoriasis: A nationwide Swedish register study

    Article • JAAD International, June 2021, Elsevier

    Dr Marie Elisabeth Linder

  20. Use of non‐insulin antidiabetic drugs in children and young adults – A Scandinavian drug utilization study from 2010–2019

    Article • British Journal of Clinical Pharmacology, April 2021, Wiley

    Dr Marie Elisabeth Linder

  21. A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder

    Article • Current Medical Research and Opinion, March 2021, Taylor & Francis

    Dr Marie Elisabeth Linder

  22. Cancer risk in patients with primary immune thrombocytopenia – A Swedish nationwide register study

    Article • Cancer Epidemiology, December 2020, Elsevier

    Dr Marie Elisabeth Linder

  23. Influence of statin‐potency on the risk of kidney disease – A nationwide cohort study using laboratory data

    Article • Pharmacoepidemiology and Drug Safety, November 2020, Wiley

    Dr Marie Elisabeth Linder

  24. <p>Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden</p>

    Article • Clinical Epidemiology, October 2020, Taylor & Francis

    Dr Marie Elisabeth Linder

  25. Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab

    Article • Pharmacoepidemiology and Drug Safety, September 2020, Wiley

    Dr Marie Elisabeth Linder

  26. <p>The Occurrence of Metabolic Risk Factors Stratified by Psoriasis Severity: A Swedish Population-Based Matched Cohort Study</p>

    Article • Clinical Epidemiology, July 2020, Taylor & Francis

    Dr Marie Elisabeth Linder

  27. Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication

    Article • European Journal of Clinical Pharmacology, March 2020, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  28. Methods for constructing treatment episodes and impact on exposure-outcome associations

    Article • European Journal of Clinical Pharmacology, November 2019, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  29. Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia

    Article • Blood Coagulation & Fibrinolysis, October 2019, Wolters Kluwer Health

    Dr Marie Elisabeth Linder

  30. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia – Results from two nationwide cohorts

    Article • Thrombosis Research, June 2019, Elsevier

    Dr Marie Elisabeth Linder

  31. Adult height is associated with risk of cancer and mortality in 5.5 million Swedish women and men

    Article • Journal of Epidemiology & Community Health, May 2019, BMJ

    Dr Marie Elisabeth Linder

  32. Classification and characteristics of on‐label and off‐label apixaban use in Denmark and Sweden

    Article • Pharmacoepidemiology and Drug Safety, April 2019, Wiley

    Dr Marie Elisabeth Linder

  33. Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer

    Article • Clinical Epidemiology, January 2019, Dove Medical Press

    Dr Marie Elisabeth Linder

  34. Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

    Article • Blood, November 2018, American Society of Hematology

    Dr Marie Elisabeth Linder

  35. Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom

    Article • PLoS ONE, September 2018, PLOS

    Dr Marie Elisabeth Linder

  36. Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany

    Article • Pharmacoepidemiology and Drug Safety, July 2018, Wiley

    Dr Marie Elisabeth Linder

  37. Young patients with risk factors prevalent in the elderly – differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers

    Article • Clinical Epidemiology, June 2018, Dove Medical Press

    Dr Marie Elisabeth Linder

  38. Erratum

    Article • Pharmacoepidemiology and Drug Safety, March 2018, Wiley

    Dr Marie Elisabeth Linder

  39. Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study

    Article • BMJ Open Diabetes Research & Care, January 2018, BMJ

    Dr Marie Elisabeth Linder

  40. Methods for time-varying exposure related problems in pharmacoepidemiology: An overview

    Article • Pharmacoepidemiology and Drug Safety, December 2017, Wiley

    Dr Marie Elisabeth Linder

  41. Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study

    Article • Thrombosis Research, December 2017, Elsevier

    Dr Marie Elisabeth Linder

  42. Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study

    Article • BMJ Open Diabetes Research & Care, May 2017, BMJ

    Dr Marie Elisabeth Linder

  43. Palivizumab Exposure and the Risk of Atopic Dermatitis, Asthma and Allergic Rhinoconjunctivitis: A Cross-National, Population-Based Cohort Study

    Article • Pediatric Drugs, February 2017, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  44. Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany

    Article • Pharmacoepidemiology and Drug Safety, January 2017, Wiley

    Dr Alexandra Prados-Torres, Dr Susana Perez-Gutthann, Dr Marie Elisabeth Linder

  45. Palivizumab Exposure and the Risk of Autoimmune Disease: A Cross-National Cohort Study

    Article • Pediatric Drugs, September 2016, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  46. Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries

    Article • BMJ, August 2016, BMJ

    Dr Marie Elisabeth Linder

  47. Increased susceptibility to infections before the diagnosis of immune thrombocytopenia

    Article • Journal of Thrombosis and Haemostasis, April 2016, Elsevier

    Dr Marie Elisabeth Linder

  48. Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence

    Article • European Journal of Clinical Pharmacology, December 2015, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  49. Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children

    Article • Journal of Allergy and Clinical Immunology, August 2015, Elsevier

    Dr Marie Elisabeth Linder

  50. Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins

    Article • Menopause, April 2015, Wolters Kluwer Health

    Dr Marie Elisabeth Linder

  51. It is possible to identify complex diseases using national health registers

    Article • Clinical Epidemiology, January 2015, Taylor & Francis

    Dr Marie Elisabeth Linder

  52. Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies

    Article • Clinical Epidemiology, December 2014, Taylor & Francis

    Dr Marie Elisabeth Linder

  53. Birth Outcomes in Women with Inflammatory Bowel Disease

    Article • Inflammatory Bowel Diseases, May 2014, Wolters Kluwer Health

    Dr Marie Elisabeth Linder

  54. Family history of cardiovascular disease and influence on statin therapy persistence

    Article • European Journal of Clinical Pharmacology, March 2014, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  55. Risks of Malignant and Non-Malignant Tumours in Tall Women Treated with High-Dose Oestrogen during Adolescence

    Article • Hormone Research in Paediatrics, January 2014, Karger Publishers

    Professor Lars Sävendahl, Dr Marie Elisabeth Linder

  56. Complications From Inflammatory Bowel Disease During Pregnancy and Delivery

    Article • Clinical Gastroenterology and Hepatology, November 2012, Elsevier

    Dr Marie Elisabeth Linder

  57. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden

    Article • British Journal of Dermatology, July 2012, Oxford University Press (OUP)

    Dr Marie Elisabeth Linder

  58. New modes of data partitioning based on PARS peak alignment for improved multivariate biomarker/biopattern detection in 1H-NMR spectroscopic metabolic profiling of urine

    Article • Metabolomics, March 2006, Springer Science + Business Media

    Dr Marie Elisabeth Linder

  59. Precision of prediction in second-order calibration, with focus on bilinear regression methods

    Article • Journal of Chemometrics, January 2002, Wiley

    Dr Marie Elisabeth Linder

  60. Second-order calibration: bilinear least squares regression and a simple alternative

    Article • Chemometrics and Intelligent Laboratory Systems, August 1998, Elsevier

    Dr Marie Elisabeth Linder